Lifestance Health Group Inc
NASDAQ:LFST

Watchlist Manager
Lifestance Health Group Inc Logo
Lifestance Health Group Inc
NASDAQ:LFST
Watchlist
Price: 7.335 USD -0.07% Market Closed
Market Cap: $2.9B

Lifestance Health Group Inc
Investor Relations

LifeStance Health Group Inc., emerging as a prominent player in the rapidly evolving behavioral health sector, operates with a mission to positively impact the lives of individuals facing mental health challenges across the United States. Founded in 2017, the company recognized the increasing demand for accessible, high-quality mental health services amidst a backdrop of rising awareness and destigmatization of mental health issues. LifeStance Health offers a comprehensive range of services, including therapy, psychiatric evaluations, and medication management. It facilitates these services both online through telehealth platforms and in-person at a multitude of clinics, effectively bridging the gap between patients and care providers. The adaptability of their hybrid model not only expands their reach but also caters to varying patient needs, particularly crucial in a post-pandemic world where digital solutions have become indispensable.

LifeStance Health generates revenue through a fee-for-service business model, deriving income primarily from patient billing and insurance reimbursements. The company's network comprises a diverse array of licensed therapists, psychiatrists, and psychologists who deliver personalized care, thus operating both as salaried employees and through revenue-sharing arrangements at their numerous practice locations. By scaling a vast provider network, LifeStance maintains significant leverage with insurance companies, negotiating favorable reimbursement rates which are central to its revenue strategy. Additionally, the organization benefits from being at the forefront of mental health service delivery innovations, which positions it strategically to adapt and grow in a marketplace that increasingly values integration of mental health into broader healthcare frameworks.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2025
Call Date
Nov 6, 2025
AI Summary
Q3 2025

Record Quarter: LifeStance delivered its strongest quarter since going public, with record visit growth, clinician net adds, and margins.

Strong Growth: Revenue rose 16% YoY to $364 million, driven by a 17% increase in visit volumes and improved clinician productivity.

Profitability Milestones: Adjusted EBITDA reached $40 million (up 31% YoY) and net income was positive for the second time in company history.

Raised Guidance: Full-year adjusted EBITDA and center margin guidance were raised, while revenue guidance midpoint was maintained.

Tech & Productivity: Operational initiatives, including tech enhancements and a new Cash Incentive Program, drove record productivity gains.

Strategic Partnerships: New partnership with Calm expands referral channels and targets a younger demographic.

Financial Flexibility: Strong cash flow and balance sheet support potential acquisitions and future investments.

2026 Outlook: Management expects mid-teens revenue growth and continued margin expansion, driven by clinician growth, productivity initiatives, and tech enablement.

Key Financials
Revenue
$364 million
Adjusted EBITDA
$40 million
Net Income
$1.1 million
Visit Volumes
2.3 million
Organic Clinician Net Adds
288
Clinician Count
7,996
Revenue per Visit
$158
Center Margin
$117 million
Center Margin Percentage
32%
Adjusted EBITDA Margin
11.1%
Free Cash Flow
$17 million
Cash Balance
$204 million
Net Long-term Debt
$269 million
DSO (Days Sales Outstanding)
31 days
Leverage Ratio (Net)
0.6x
Leverage Ratio (Gross)
2x
Q4 Revenue Guidance
$368–$388 million
Q4 Center Margin Guidance
$113–$127 million
Q4 Adjusted EBITDA Guidance
$37–$43 million
Expected New Centers Opened 2025
20–25
Stock-based Compensation Expectation
$70–$85 million
Specialty Services Revenue
$50 million (annualized)
Earnings Call Recording
Other Earnings Calls

Management

Mr. Kenneth Alan Burdick
CEO & Chairman
No Bio Available
Mr. David Patrick Bourdon
Chief Financial Officer & Treasurer
No Bio Available
Mr. Pablo Pantaleoni
Chief Digital Officer
No Bio Available
Ms. Monica Prokocki
Vice President of Investor Relations
No Bio Available
Brooke Matthews
Director of Public Relations
No Bio Available
Ms. Ann Varanakis
Chief People Officer
No Bio Available
Dr. Ujjwal Ramtekkar CPE, M.B.A., M.D.
Chief Medical Officer
No Bio Available
Mr. Richard Hall
Executive Vice President of Shared Services
No Bio Available
Ms. Lisa Keise Miller
Executive Vice President of Practice Operations
No Bio Available
Ms. Toi Valentine
Senior VP & Chief Strategy Officer
No Bio Available

Contacts

Address
ARIZONA
Scottsdale
4800 N. Scottsdale Road, Suite 6000
Contacts